DrugMar 22, 2023
Breckenridge Pharmaceutical Alprazolam Tablets, USP, 1 mg, CIV recall — FDA D-0460-2023
CGMP Deviations: Potential risk of Cross Contamination
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 70
10,685 detailed records are currently available in this category.
DrugMar 22, 2023
Breckenridge Pharmaceutical Alprazolam Tablets, USP, 0.25mg, CIV recall — FDA D-0458-2023
CGMP Deviations: Potential risk of Cross Contamination
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
DrugMar 22, 2023
Breckenridge Pharmaceutical Alprazolam Tablets, USP, 0.5mg, CIV recall — FDA D-0459-2023
CGMP Deviations: Potential risk of Cross Contamination
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
DrugMar 22, 2023
AVEVA Drug Delivery Systems Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 recall — FDA D-0466-2023
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Class IIIFDA: TerminatedAVEVA Drug Delivery Systems, Inc.
DrugMar 22, 2023
AVEVA Drug Delivery Systems Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 recall — FDA D-0465-2023
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
Class IIIFDA: TerminatedAVEVA Drug Delivery Systems, Inc.
DrugMar 22, 2023
Evamist recall — FDA D-0464-2023
Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Class IIIFDA: OngoingPadagis US LLC
DrugMar 22, 2023
Breckenridge Pharmaceutical Alprazolam Tablets, USP, 2 mg, CIV recall — FDA D-0461-2023
CGMP Deviations: Potential risk of Cross Contamination
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
DrugMar 22, 2023
Teva Pharmaceuticals USA Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine recall — FDA D-0469-2023
Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Class IIFDA: TerminatedTeva Pharmaceuticals USA Inc.
DrugMar 15, 2023
Nanomaterials Discovery Snowy Range Blue Alcohol Antiseptic 80% Topical Solution Hand recall — FDA D-0455-2023
Chemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits.
Class IFDA: OngoingNanomaterials Discovery Corporation
DrugMar 15, 2023
Brimonidine Tartrate Ophthalmic Solution 0.15% recall — FDA D-0433-2023
Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
Class IIFDA: CompletedApotex Corp.
DrugMar 15, 2023
Pharmedica USA Purely Soothing 15% MSM Drops recall — FDA D-0456-2023
Non-Sterility
Class IFDA: OngoingPharmedica USA, LLC
DrugMar 15, 2023
Nutraceutical NatraBio, Cold& Sinus Nasal Spray, Homeopathic Medicine, 0.8 FL Oz. ( 24ml) recall — FDA D-0438-2023
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Class IIFDA: OngoingNutraceutical Corporation
DrugMar 15, 2023
Teva Pharmaceuticals USA Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count recall — FDA D-0441-2023
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Class IIFDA: TerminatedTeva Pharmaceuticals USA Inc.
DrugMar 15, 2023
Nutraceutical NaturalCare, children's, Allergy Care, Homeopathic, 4 Months and Up, Liquid recall — FDA D-0440-2023
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Class IIFDA: OngoingNutraceutical Corporation
DrugMar 15, 2023
Amerisource Health Services Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg recall — FDA D-0436-2023
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Class IIFDA: TerminatedAmerisource Health Services LLC
DrugMar 8, 2023
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle recall — FDA D-0354-2023
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Class IIIFDA: TerminatedSciegen Pharmaceuticals Inc.
DrugMar 8, 2023
Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle recall — FDA D-0384-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle recall — FDA D-0353-2023
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Class IIFDA: TerminatedAlvogen, Inc.
DrugMar 8, 2023
Atorvastatin Calcium Tablets USP 80 mg* recall — FDA D-0374-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
BusPIRone Hydrochloride Tablets USP 30 mg, 60-count bottle recall — FDA D-0379-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
Montelukast Sodium Tablets, USP, 10 mg* recall — FDA D-0400-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugMar 8, 2023
DuPont Nutrition USA BD-102 NF, Microcrystalline Cellulose, NF, Ph recall — FDA D-0352-2023
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Class IIIFDA: TerminatedDuPont Nutrition USA, Inc.
DrugMar 8, 2023
Volt Candy Wholesale Club PrimeZEN Black 6000 capsule, 2000mg, Male Sexual Performance recall — FDA D-0453-2023
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
Class IFDA: TerminatedVolt Candy Wholesale Club
DrugMar 8, 2023
Atorvastatin Calcium Tablets USP 40 mg* recall — FDA D-0373-2023
CGMP Deviations: recalling drug products following an FDA inspection.
Class IIFDA: TerminatedAccord Healthcare, Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.